NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of bleeding disorders

COMMERCIAL MEDICINES UNITcontractContracts FinderRef CM/PHS/14/5434SME suitablecomplete
View buyer

Estimated value

£50.6m

Awarded value

£41.0m

Awarded 02 Jun 2016

Suppliers

1

Lots

1

1 awarded

Published

17 Aug 2018

Deadline 23 Mar 2016

Description

The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England, Wales, Scotland and Northern Ireland. The framework may also be used by private sector contractors and agents working on behalf of the above. Please refer to Document 05d in the ITO documents for the list of Participating Authorities.

Scope

Reference
CM/PHS/14/5434
Total value
£50,600,000 excluding VAT
Commercial tool
Standalone contract
Contract dates
31 Aug 2016 to 28 Feb 2019
CPV classifications
33141000 33620000
Particular suitability
Small and medium-sized enterprises (SME)

Submission & procedure

Submission deadline
23 Mar 2016, 12:00 am

Award details

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

£41.0m

Award date

02 Jun 2016

Contract start

31 Aug 2016

Contract end

28 Feb 2019